Trivarx Ltd has released a press release.
March 2025 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- IRB approval for trial with US Dept of Veterans Affairs
- TrivarX Receives Firm Commitments to Raise $2.25 million
- Trial with US Department of Veterans Affairs
- Appendix 4D & Half-Year Financial Report to 31 December 2024
- December 2024 Quarterly Activities Report and Appendix 4C
Later from TrivarX
- First patient recruited in innovative mental health trial
- June 2025 Quarterly Activities Report and Appendix 4C
- Appendix 4E - Preliminary Final Report
- Trading Halt
- Positive interim results from US-veteran focused trial
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX